This effect was partly through the reduction of the canonical signaling of TGF-β pathway and by recovering antioxidant enzyme expression in adenine-induced kidney damage or decreasing inflammatory response by reducing nuclear factor kappa B (NF-κB) activation in UUO [72]. The gene discussed is TGFB1; the disease is Nephropathy.